Market Cap

Parenteral Drugs Market Capitalization:

₹101.1 Million

INR as of Jan. 1, 2024

US$1.2 Million

business Parenteral Drugs Company Profile

Parenteral Drugs Main Stock Listing

NSE: PDPL

Market Capitalization History of Parenteral Drugs

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Parenteral Drugs market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₹101.1 M -32.74%
Jan. 1, 2023 ₹150.3 M 1.27%
Jan. 1, 2022 ₹148.4 M 51.92%
Jan. 1, 2021 ₹97.7 M 0.00%
Jan. 1, 2020 ₹97.7 M -77.19%
Jan. 1, 2019 ₹428.3 M -46.85%
Jan. 1, 2018 ₹805.8 M -4.45%
Jan. 1, 2017 ₹843.4 M -62.01%
Jan. 1, 2016 ₹2.22 B 165.62%
Jan. 1, 2015 ₹835.9 M -23.93%
Jan. 1, 2014 ₹1.10 B -71.32%
Jan. 1, 2013 ₹3.83 B -5.64%
Jan. 1, 2012 ₹4.06 B -54.72%
Jan. 1, 2011 ₹8.97 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Parenteral Drugs Categories

India languages Healthcare languages Drug Manufacturers—Specialty & Generic
India Healthcare India Drug Manufacturers—Specialty & Generic

Stocks & Indices

Parenteral Drugs has the following listings and related stock indices.


Stock: NSE: PDPL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.